E25Bio COVID-19 Direct Antigen Rapid Tests

Case Name (Date)

Urena et al. v. E25Bio Inc.
22-cv-1379, S.D.N.Y.
(Feb. 2022)

Product/Service

E25Bio COVID-19 Direct Antigen Rapid Tests

Allegations

Falsely marketing tests as accurate when they are significantly less accurate than other at-home tests

Falsely representing that tests are authorized by the FDA

Status

Voluntarily dismissed When a complaint is dismissed without prejudice, an amended version of the complaint can be refiled.